Abstract
The guinea pig model of disease has been considered synonymous with the experimental laboratory animal since the nineteenth century. Recently we have reviewed the use of this species in models of bacterial infectious disease. The present review extends to viral diseases for which the guinea pig is less frequently considered the relevant animal model. The use of the guinea pig as a laboratory animal, aspects of immunology, viral pathogens and host-pathogen models are discussed. As a small and relatively inexpensive model for infection and immunity the guinea pig has a significant future but there are substantial requirements for development of validated quantitative analytical methods for immunological and disease biomarkers if it is to reach its potential.
Keywords: guinea pig, immunology, viruses, animal model, antiviral drugs, bacterial diseases, pathogens, delayed-type hypersensivity, Baltimore virus, genome
Current Drug Targets
Title: Guinea Pig Model of Infectious Disease - Viral Infections
Volume: 12 Issue: 7
Author(s): Anthony J. Hickey
Affiliation:
Keywords: guinea pig, immunology, viruses, animal model, antiviral drugs, bacterial diseases, pathogens, delayed-type hypersensivity, Baltimore virus, genome
Abstract: The guinea pig model of disease has been considered synonymous with the experimental laboratory animal since the nineteenth century. Recently we have reviewed the use of this species in models of bacterial infectious disease. The present review extends to viral diseases for which the guinea pig is less frequently considered the relevant animal model. The use of the guinea pig as a laboratory animal, aspects of immunology, viral pathogens and host-pathogen models are discussed. As a small and relatively inexpensive model for infection and immunity the guinea pig has a significant future but there are substantial requirements for development of validated quantitative analytical methods for immunological and disease biomarkers if it is to reach its potential.
Export Options
About this article
Cite this article as:
J. Hickey Anthony, Guinea Pig Model of Infectious Disease - Viral Infections, Current Drug Targets 2011; 12 (7) . https://dx.doi.org/10.2174/138945011795677827
DOI https://dx.doi.org/10.2174/138945011795677827 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mouse Models of Multiple Sclerosis: Lost in Translation?
Current Pharmaceutical Design Current Status of Anti-Picornavirus Therapies
Current Pharmaceutical Design Structural Heterogeneity and Multifunctionality of Lactoferrin
Current Protein & Peptide Science Pathogenesis of Stroke-Like Episodes in MELAS: Analysis of Neurovascular Cellular Mechanisms
Current Neurovascular Research The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies
Current Medicinal Chemistry The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Directing the Antiretroviral Drugs to the Brain Reservoir: A Nanoformulation Approach for NeuroAIDS
Current Drug Metabolism Editorial [Hot Topic: Protein Peptide Informatics and Drug Designing - Some Computational Techniques for Structural Genomics Based Approaches (Part II) (Guest Editor: Rajani R. Joshi)]
Protein & Peptide Letters Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers
Current Pharmaceutical Design Plasmid DNA Manufacturing Technology
Recent Patents on Biotechnology Glycyrrhizic Acid Derivatives as New Antiviral and Immune Modulating Agents
Current Bioactive Compounds Autoantibodies Among HIV-1 Infected Individuals and the Effect of Anti-Retroviral Therapy (ART) on It
Current HIV Research Emerging Evidence for Neuropsycho-Consequences of COVID-19
Current Neuropharmacology Recent Advances in Biological Strategies for Targeted Drug Delivery
Cardiovascular & Hematological Disorders-Drug Targets Recent Patents on Alphavirus Protein Expression and Vector Production
Recent Patents on Biotechnology Non-Celiac Gluten Sensitivity Triggers Gut Dysbiosis, Neuroinflammation, Gut-Brain Axis Dysfunction, and Vulnerability for Dementia
CNS & Neurological Disorders - Drug Targets Targeting Pattern Recognition Receptors (PRRs) in Nano- Adjuvants: Current Perspectives
Current Bionanotechnology (Discontinued) Editorial (Thematic Issue: Neuroglia as a Central Element of Neurological Diseases: An Underappreciated Target for Therapeutic Intervention)
Current Neuropharmacology A Case Presentation of Atypical X-linked Adrenoleukodystrophy: Initial Experience with ASL Technique
Current Medical Imaging A Coadunation of Biological and Mathematical Perspectives on the Pandemic COVID-19: A Review
Coronaviruses